Australia’s oldest lending library lists historic CBD tower for $40m
The Sydney Mechanics’ School of Arts is selling its building at 280 Pitt Street.
Latest articles and price-sensitive announcements with AI sentiment classification.
The Sydney Mechanics’ School of Arts is selling its building at 280 Pitt Street.

Melbourne-based investment firm Quintessential Equity has acquired 133 Mary Street in Brisbane's CBD for $81.8 million, betting on a value-add repositioning of the 15-level office tower ahead of a new train station opening just 100 metres from the building in 2029. The deal, brokered by CBRE's Peter Chapple and JLL's Paul Noonan, co...

An undisclosed local investor has snapped up Grenfell Car Park, a 500-bay facility in Adelaide's CBD, from a fund managed by Growthpoint Properties Australia (ASX: GOZ) after a competitive sales process that delivered a premium to book value. The seven-level car park at 90-100 Grenfell Street sits on a 2,416sqm site and is fully l...

South-East Queensland has cemented its position as the country's strongest office market, with the Property Council of Australia's latest Office Market Report revealing Brisbane CBD has recorded the lowest CBD vacancy rate in the nation at 10.2 per cent while the Gold Coast posted the lowest overall office vacancy rate of any market in A...

Billbergia Group and alternative asset manager Metrics Credit Partners have made an early start to construction after securing City of Sydney approval for Castlereagh Place, a $3.5 billion mixed-use development comprising two 82-storey towers that will rank among the tallest residential buildings in the city. The joint venture, which acqui...
Chinatown abuzz as 200 spectators watched two bidders in a heated 40-minute contest.
Highlights No Schedule three CBD products have yet reached Australian pharmacy shelves despite regulatory expectations. Most medicinal cannabis access remains tied to prescription-based pathways. ASX cannabis sentiment remains closely linked to regulatory timing and approval progress. Australia’s CBD rollout remains stalled at the pharmacy level, keeping ASX cannabis stocks focused on regulatory progress and prescription-based distribution models. Australia’s cannabis sector...